CENPO expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.425000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.746400E-01
Normal-vs-Stage2
8.839800E-01
Normal-vs-Stage3
2.543000E-01
Normal-vs-Stage4
9.401600E-01
Stage1-vs-Stage2
8.006800E-01
Stage1-vs-Stage3
2.364200E-01
Stage1-vs-Stage4
9.081400E-01
Stage2-vs-Stage3
1.145990E-01
Stage2-vs-Stage4
9.394600E-01
Stage3-vs-Stage4
2.062400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.037200E-01
Normal-vs-AfricanAmerican
9.278200E-01
Normal-vs-Asian
6.802200E-01
Caucasian-vs-AfricanAmerican
9.841400E-01
Caucasian-vs-Asian
3.354600E-01
AfricanAmerican-vs-Asian
5.357800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.607200E-01
Normal-vs-Female
8.252800E-01
Male-vs-Female
2.826600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.736000E-01
Normal-vs-Age(41-60Yrs)
7.748000E-01
Normal-vs-Age(61-80Yrs)
9.367200E-01
Normal-vs-Age(81-100Yrs)
6.440400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.595600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.395800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.369600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.793180E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.135200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.933420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.839600E-01
Normal-vs-Daily Drinker
9.572800E-01
Normal-vs-Weekly Drinker
8.082800E-01
Normal-vs-Occasional Drinker
9.735200E-01
Normal-vs-Social Drinker
8.256800E-01
Non Drinker-vs-Daily Drinker
6.634600E-01
Non Drinker-vs-Weekly Drinker
4.373400E-01
Non Drinker-vs-Occasional Drinker
7.102600E-01
Non Drinker-vs-Social Drinker
4.865000E-01
Daily Drinker-vs-Weekly Drinker
6.377000E-01
Daily Drinker-vs-Occasional Drinker
9.681200E-01
Daily Drinker-vs-Social Drinker
7.201600E-01
Weekly Drinker-vs-Occasional Drinker
6.374800E-01
Weekly Drinker-vs-Social Drinker
8.886000E-01
Occasional Drinker-vs-Social Drinker
7.069200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.784800E-01
Normal-vs-Grade 2
7.503800E-01
Normal-vs-Grade 3
7.986800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.582100E-02
Grade 1-vs-Grade 3
8.355500E-03
Grade 1-vs-Grade 4
6.784800E-01
Grade 2-vs-Grade 3
1.764400E-01
Grade 2-vs-Grade 4
7.503800E-01
Grade 3-vs-Grade 4
7.986800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.775600E-01
Normal-vs-NonDiabetic
9.387400E-01
Diabetic-vs-NonDiabetic
2.521400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.777200E-01
Normal-vs-NoPancreatitis
9.785600E-01
Pancreatitis-vs-NoPancreatitis
3.539600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.834000E-01
Normal-vs-N1
8.712400E-01
N0-vs-N1
5.181600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.344400E-01
Normal-vs-TP53-NonMutant
9.298400E-01
TP53-Mutant-vs-TP53-NonMutant
1.163040E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
